Generated by Meeveem AI
"Integrated biopharmaceutical solutions accelerating novel therapies from clinical trials to market"
Syneos Health combines clinical research, medical affairs, and commercial expertise to help biopharmaceutical companies bring new therapies to market faster. The company specialises in late stage clinical trials and commercialisation services, having supported the development or market launch of 93 percent of novel drugs approved by the FDA in the past five years, including 96 percent of oncology treatments. The company partners with biopharma organisations at every stage from preclinical research through full commercialisation. With over 23,000 employees including 480 MDs and 750 PhDs, Syneos Health delivers integrated solutions designed to reduce risk and speed life changing therapies to patients worldwide.
23205
Team Members
2018
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where life changing therapies reach patients faster through seamless clinical to commercial integration
At Syneos Health, our mission is to shorten the distance from lab to life by accelerating customer success and speeding the delivery of important therapies to patients.